| Date Filed | Type | Description |
| 06/09/2023 |
4
| GILL DAVID N (Director) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 2,330 shares
@ $0
Granted 13,950 options to buy
@ $8.13, valued at
$113.4k
|
|
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2022 |
4
| GILL DAVID N (Director) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 16,000 options to buy
@ $16.64, valued at
$266.2k
|
|
| 05/17/2022 |
4
| GILL DAVID N (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Sold 5,313 shares
@ $13.097, valued at
$69.6k
Sold 5,000 shares
@ $13.616, valued at
$68.1k
|
|
| 01/26/2022 |
4
| GILL DAVID N (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 15,568 shares
@ $0
Granted 22,727 options to buy
@ $5.46, valued at
$124.1k
|
|
| 10/06/2021 |
4
| GILL DAVID N (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Disposed/sold 78,058 shares
@ $0 |
|
| 10/05/2021 |
4
| GILL DAVID N (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Paid exercise price by delivering 17,763 shares
@ $2.06, valued at
$36.6k
|
|
| 06/14/2021 |
4
| GILL DAVID N (Director) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 16,000 options to buy
@ $37.53, valued at
$600.5k
|
|
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| GILL DAVID N (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 19,313 shares
@ $0 |
|
| 01/20/2021 |
4
| GILL DAVID N (Director) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Sold 2,000 shares
@ $46.5226, valued at
$93k
Exercised 2,000 options to buy
@ $11.16, valued at
$22.3k
|
|
| 11/20/2020 |
4
| GILL DAVID N (Director) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Sold 2,000 shares
@ $45.765, valued at
$91.5k
Exercised 2,000 options to buy
@ $11.16, valued at
$22.3k
|
|
| 11/05/2020 |
4
| GILL DAVID N (Director) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Sold 4,000 shares
@ $45, valued at
$180k
Exercised 4,000 options to buy
@ $11.16, valued at
$44.6k
|
|
| 09/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2020 |
4
| GILL DAVID N (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 23,458 options to buy
@ $10.19, valued at
$239k
|
|
| 11/26/2019 |
4
| GILL DAVID N (Director) has filed a Form 4 on STRATA Skin Sciences, Inc.|
Txns:
| Granted 18,293 shares
@ $0 |
|
| 09/04/2019 |
4
| GILL DAVID N (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Granted 50,000 shares
@ $0 |
|
| 09/04/2019 |
3
| GILL DAVID N (Director) has filed a Form 3 on Strongbridge Biopharma plc |
| 06/14/2019 |
4
| GILL DAVID N (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Bought 2,000 shares
@ $13.65, valued at
$27.3k
|
|
| 06/14/2019 |
4
| GILL DAVID N (Director) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 16,000 options to buy
@ $21.45, valued at
$343.2k
|
|
| 06/12/2019 |
4
| GILL DAVID N (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 30,000 options to buy
@ $0 |
|
| 01/25/2019 |
4
| GILL DAVID N (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 14,500 options to buy
@ $16.19, valued at
$234.8k
|
|
| 12/17/2018 |
4
| GILL DAVID N (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Bought 3,000 shares
@ $12.7667, valued at
$38.3k
|
|
| 09/20/2018 |
3
| GILL DAVID N (Director) has filed a Form 3 on Y-mAbs Therapeutics, Inc. |
| 07/17/2018 |
4/A
| GILL DAVID N (Director) has filed a Form 4 on STRATA Skin Sciences, Inc.|
Txns:
| Granted 31,401 shares
@ $0 |
|
| 06/19/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2018 |
4
| GILL DAVID N (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 25,000 options to buy
@ $7.45, valued at
$186.3k
Granted 9,100 options to buy
@ $7.45, valued at
$67.8k
|
|
| 06/11/2018 |
4
| GILL DAVID N (Director) has filed a Form 4 on STRATA Skin Sciences, Inc.|
Txns:
| Granted 26,570 options to buy
@ $2.07, valued at
$55k
|
|
| 05/30/2018 |
4
| GILL DAVID N (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Bought 5,000 shares
@ $6.09, valued at
$30.5k
|
|
| 05/30/2018 |
3
| GILL DAVID N (Director) has filed a Form 3 on STRATA Skin Sciences, Inc. |
|